Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page
- Check8 days agoChange DetectedVersion updated from v3.4.2 to v3.4.3; a minor update/patch.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded expanded Study Results data with new safety and laboratory outcome tables, including TEAEs/SAEs by SOC and PT, vital signs, and laboratory abnormalities across dose groups; introduced 'Number Analyzed' and 'Overall Number of Participants Analyzed' details.SummaryDifference24%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous v3.4.1. This metadata change does not alter any study results or core content.SummaryDifference0.0%

- Check36 days agoChange DetectedFooter revision updated to v3.4.1. No other content changes to the study results page are evident.SummaryDifference0.0%

- Check51 days agoChange DetectedGlossary toggle added to the page; QC-related submission timestamps were updated (First Submitted that Met QC Criteria, Results First Submitted that Met QC Criteria, Last Update Submitted that Met QC Criteria) and Last Update Posted. A new Walsh J. et al. publication was added to publications, the older Walsh citation was removed, No FEAR Act Data was added, and the revision version updated to v3.4.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.3.4 has been added and v3.3.3 removed, reflecting a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.